We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

110 hedge funds and large institutions have $260M invested in Surmodics in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more call options, than puts

Call options by funds: $647K | Put options by funds: $347K

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

1% more funds holding

Funds holding: 109110 (+1)

3% less capital invested

Capital invested by funds: $269M → $260M (-$9.38M)

35% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 49

Holders
110
Holders Change
+1
Holders Change %
+0.92%
% of All Funds
3.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
32
Reduced
49
Closed
9
Calls
$647K
Puts
$347K
Net Calls
+$300K
Net Calls Change
+$166K

SRDX Hedge Fund Activity: Q1 2014 in Review

110 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2014, worth a combined $260M — down 3.5% from $269M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SRDX positions and 9 closed out — a net gain of 2 holders — while 32 added to existing stakes and 49 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $18.8M. The largest seller was First Trust Advisors, exiting entirely with an estimated $6.45M sold.

  • 110 institutional investors held Surmodics (SRDX) as of Q1 2014, up from 109 in Q4 2013.
  • Funds reported $260M of Surmodics stock for Q1 2014, down 3.5% quarter-over-quarter.
  • 11 funds opened new Surmodics positions in Q1 2014 and 9 closed out, a net change of +2 holders.
  • The largest Surmodics buyer in Q1 2014 was Wellington Management Group, an estimated $18.8M added.
  • The largest Surmodics seller in Q1 2014 was First Trust Advisors, an estimated $6.45M sold.

Based on aggregated 13F filings for Q1 2014.